It’s been well established that each patient treated corresponds to a $1600 kit sourced from CELZ. Now, what we don’t know, or at least I don’t know for certain, is how much CELZ pays for the kit? The difference being their profit.
So, ALL of the CaverStem and FemCelz treated patients will generate revenue. We will see the numbers at each Q.
When the 10k hits this month it will only show last year, so yes, we will be waiting for Q1 this year to see the revenue from these new offices opening.
As we have all speculated, that will be Q after Q growth for a while as patient numbers and office numbers expand.
The next question for me is, when do we see either news or market awareness that causes a frenzy on buying?